Clinical Assessment and Mutation Analysis of Kallmann Syndrome 1 (<i>KAL1</i>) and Fibroblast Growth Factor Receptor 1 (<i>FGFR1</i>, or<i>KAL2</i>) in Five Families and 18 Sporadic PatientsNaoko Sato, Tsutomu Ogata, Yasuhiro Naiki et al.|The Journal of Clinical Endocrinology & Metabolism|2004Cited by 220
Cytochrome P450 Oxidoreductase Gene Mutations and Antley-Bixler Syndrome with Abnormal Genitalia and/or Impaired Steroidogenesis: Molecular and Clinical Studies in 10 PatientsMaki Fukami, Tsutomu Ogata, Reiko Horikawa et al.|The Journal of Clinical Endocrinology & Metabolism|2005Cited by 159
Urine Steroid Hormone Profile Analysis in Cytochrome P450 Oxidoreductase Deficiency: Implication for the Backdoor Pathway to DihydrotestosteroneKeiko Homma, Tsutomu Ogata, Tomonobu Hasegawa et al.|The Journal of Clinical Endocrinology & Metabolism|2006Cited by 155
Protein-Tyrosine Phosphatase, Nonreceptor Type 11 Mutation Analysis and Clinical Assessment in 45 Patients with Noonan SyndromeRie Yoshida, Tsutomu Ogata, Tomonobu Hasegawa et al.|The Journal of Clinical Endocrinology & Metabolism|2004Cited by 115
Cytochrome P450 Oxidoreductase Deficiency: Identification and Characterization of Biallelic Mutations and Genotype-Phenotype Correlations in 35 Japanese PatientsMaki Fukami, Tsutomu Ogata, Gen Nishimura et al.|The Journal of Clinical Endocrinology & Metabolism|2009Cited by 114